CAPTRUST Financial Advisors’s Ascendis Pharma A/S ASND Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-28,051	Closed	-$3.53M	–	2173
2023 Q4	$3.53M	Buy	28,051 +4,022	+17%	+$401K	0.01%	681
2023 Q3	$2.25M	Buy	24,029 +11,708	+95%	+$1.1M	0.01%	819
2023 Q2	$1.1M	Sell	12,321 -4	-0%	-$348	﹤0.01%	1146
2023 Q1	$1.32M	Hold	12,325	–	–	0.01%	899
2022 Q4	$1.51M	Buy	+12,325	New	+$1.43M	0.01%	807
2022 Q3	–	Sell	-1,594	Closed	-$148K	–	2197
2022 Q2	$148K	Buy	1,594 +548	+52%	+$51.6K	﹤0.01%	1909
2022 Q1	$123K	Buy	1,046 +1,013	+3,070%	+$117K	﹤0.01%	2109
2021 Q4	$4K	Hold	33	–	–	﹤0.01%	4156
2021 Q3	$5K	Hold	33	–	–	﹤0.01%	3931
2021 Q2	$4K	Hold	33	–	–	﹤0.01%	3930
2021 Q1	$4K	Hold	33	–	–	﹤0.01%	3792
2020 Q4	$6K	Hold	33	–	–	﹤0.01%	2753
2020 Q3	$5K	Buy	33 +30	+1,000%	+$4.31K	﹤0.01%	2511
2020 Q2	$0	Buy	+3	New	+$412	﹤0.01%	2843

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CAPTRUST Financial Advisors's ASND Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2024, closing a stake of 28,051 shares — an estimated $3.53M sold.

CAPTRUST Financial Advisors first reported a position in ASND in Q2 2020 and held it in 14 quarters. The position peaked at $3.53M in Q4 2023. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

CAPTRUST Financial Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2024 after selling out during the quarter.
CAPTRUST Financial Advisors sold 28,051 Ascendis Pharma A/S shares in Q1 2024, an estimated $3.53M.
CAPTRUST Financial Advisors first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 14 quarters.
CAPTRUST Financial Advisors's Ascendis Pharma A/S position peaked at $3.53M in Q4 2023.
189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.